Literature DB >> 3622200

Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy.

P J Dyck, W Bushek, E M Spring, J L Karnes, W J Litchy, P C O'Brien, F J Service.   

Abstract

Increasingly more tests are being used to detect and characterize diabetic polyneuropathy, but their value in setting minimal criteria for the diagnosis of neuropathy and for staging severity remains inadequately studied. In 180 diabetics, we compared the percentage of patients with test abnormalities and associations among test results, evaluating neuropathic symptoms [neuropathy symptom score (NSS) and neuropathy scale of neuropathy symptom profile (NNSP)], deficits [neurologic disability score (NDS) and vibratory (VDT) and cooling (CDT) detection thresholds], or nerve dysfunction [nerve conduction (NC)]. The percentage of patients that were abnormal varied considerably depending on criteria for abnormality and the tests used. Abnormality (greater than or equal to 3 SD of 1 or more parameters) of NC of one or more of four nerves occurred in 80%, of two or more in 69%, of three or more in 46%, and of four in 21%. Similarly, for other tests, the rate of abnormality decreased with use of increasingly stringent criteria. Setting the criteria for abnormal NC at abnormality of two or more nerves, NSS at greater than or equal to 1, NDS at greater than 6, NNSP at greater than or equal to 97.5th percentile, and at greater than or equal to 95th percentile for the other tests, NC was abnormal in 69%, NSS in 54%, NDS in 48%, NNSP in 47%, VDT in 44%, and CDT in 35%. Abnormality of any two or more of the six tests evaluated occurred in 64% of patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3622200     DOI: 10.2337/diacare.10.4.432

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  33 in total

1.  Quantitative sensory testing of thermal and vibratory perception in familial dysautonomia.

Authors:  M J Hilz; F B Axelrod
Journal:  Clin Auton Res       Date:  2000-08       Impact factor: 4.435

2.  An 18-month follow-up study on vibrotactile sense, muscle strength and symptoms in computer users with and without symptoms.

Authors:  M Pilegaard; B R Jensen
Journal:  Int Arch Occup Environ Health       Date:  2005-06-14       Impact factor: 3.015

3.  Clinical features predictive of a poor prognosis in acute porphyria.

Authors:  Elena Pischik; Anton Bulyanitsa; Valery Kazakov; Raili Kauppinen
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

4.  Effects of footwear on plantar foot sensitivity: a study with Formula 1 shoes.

Authors:  Günther Schlee; Thorsten Sterzing; Thomas L Milani
Journal:  Eur J Appl Physiol       Date:  2009-03-11       Impact factor: 3.078

Review 5.  Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence.

Authors:  E A Masson; A J Boulton
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

6.  "Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy: Cl vs N Phys Trial.

Authors:  Peter J Dyck; Carol J Overland; Phillip A Low; William J Litchy; Jenny L Davies; P James B Dyck; Rickey E Carter; L Joseph Melton; Henning Andersen; James W Albers; Charles F Bolton; John D England; Christopher J Klein; Gareth Llewelyn; Michelle L Mauermann; James W Russell; Dinesh Selvarajah; Wolfgang Singer; A Gordon Smith; Solomon Tesfaye; Adrian Vella
Journal:  Arch Neurol       Date:  2012-12

7.  A comparison of nerve conduction velocities and current perception thresholds as correlates of clinical severity of diabetic sensory neuropathy.

Authors:  M S Rendell; J J Katims; R Richter; F Rowland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

8.  Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy.

Authors:  G Said; D Baudoin; K Toyooka
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

Review 9.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

10.  Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.

Authors:  John L Berk; Ole B Suhr; Laura Obici; Yoshiki Sekijima; Steven R Zeldenrust; Taro Yamashita; Michael A Heneghan; Peter D Gorevic; William J Litchy; Janice F Wiesman; Erik Nordh; Manuel Corato; Alessandro Lozza; Andrea Cortese; Jessica Robinson-Papp; Theodore Colton; Denis V Rybin; Alice B Bisbee; Yukio Ando; Shu-ichi Ikeda; David C Seldin; Giampaolo Merlini; Martha Skinner; Jeffery W Kelly; Peter J Dyck
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.